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1. Introduction 
Urinary tract infection is common in children. Before the age of 6 months; boys are more 
susceptible to UTI than girls thereafter, the incidence is substantially higher in girls than in 
boys .Up to 11.3% of girls and 3.6% of boys studied in UK will have had an UTI by age 
16years .UTI is usually caused by gram-negative organisms, especially Escherichia coli 
which accounts for about 80% of all pathogens. Proteus is more common in boys. (1, 2)  
In childhood, upper UTI with 5.3% prevalence rate, are one of the most important causes of 
hospitalization. Although acute pyelonephritis might presents with fever, lethargy, 
anorexia, and vomiting but there are no certain specific diagnostic laboratory tests and 
clinical symptoms for diagnosis of UTI (1, 2) 
Untreated upper UTI can produce severe renal damages. Delay in treatment of acute 
pyelonephritis increases the risk of kidney damage. Complications of acute pyelonephritis 
include intra renal and peri renal abscess. Early diagnosis and treatment of urinary tract 
infection in children is important (3, 4)  
Recurrent UTI is defined as a further infection by a new organism. Relapsing UTI is defined 
as a further infection with the same organism. (1-5) 
Uncomplicated UTI infection requires no imaging and often shows no imaging 
abnormalities. Children who fail to respond to treatment or are severely ill need imaging 
evaluation (11) Obstructive anomalies are found in up to 4%, and vesico ureteral reflux in 
8% to 40% of those with first urinary tract infection. Acute pyelonephritis and reflux are two 
synergistic factors in the destruction of kidneys of children (1-5) 
In children, vesico ureteral reflux of infected urine is the most common cause of chronic 
pyelonephritis and chronic interstitial nephritis. Intra renal reflux induces reflux 
nephropathy, progressive renal injury and cortical scarring. Reflux nephropathy usually 
observed as a focal cortical scar that overlies a blunted calyx in the upper pole of kidney (11) 
Imaging findings in children with reflux nephropathy is similar to chronic pyelonephritis in 
adults. Both type of nephropathy are best demonstrated on IVP or US and CT as classically 
lobar, with normal lobes with normal calyces interposed between diseased lobes. (11-17) CT 
is more sensitive than Ultrasound in demonstrating subtle changes in the renal parenchyma 
associated with uncomplicated pyelonephritis. CT is normal in some patients with mild 
uncomplicated pyelonephritis. Complications such as renal or peri renal abscess are well 
demonstrated by CT or US (17)   
Although imaging studies have been considered after the diagnosis of a first urinary tract 
infection, the effect of such studies on outcome has been unclear. Recently, low radiation 
procedures recommended for diagnosis of VUR (18) 
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Urinary tract infections accounting for a considerable percentage of antibiotic prescriptions 
in some countries (18-30) 
The prevalence of resistant gram negative organisms is increased during last decade (19, 20) 
The first febrile uncomplicated UTI in children is caused by E coli in 70% to 90% of cases. In 
recent studies a high rates of resistant uropathogens (other than E coli) to various 
antimicrobial agents in children received prophylactic antibiotics prophylaxis (21-24). So a 
high level of diagnostic accuracy is essential in view of the increasing prevalence of 
antibiotic resistance. 
2. UTI diagnosis  
The normal urinary tract is sterile. UTI is defined by pure growth of more than 10 5 colony 
forming units of bacteria per ml of urine.Urine culture is the gold standard for the diagnosis 
of UTI ,but negative urine culture reported in up to 60 to 80% of UTI cases and urine culture 
is time-consuming (4, 5) In urine sample obtained by suprapubic aspiration any growth of 
urinary pathogens is clinically important. (6) 
Upon Schmiemann et al opinion differentiating UTI from asymptomatic bacteriuria, which 
usually requires no treatment, can lower the frequency of unnecessary antibiotic 
prescriptions (7) Rapid urine tests, such as microscopy with Gram stain, for bacteria and 
white cells, and dipsticks, for leucocyte esterase and nitrites often used for diagnosis (6-7) 
In recent years, fast screening methods that can reduce the necessity for urine cultures 
studied by some authors .The Sysmex UF-1000i is a urine flow cytometer that uses two 
separate channels for counting blood cells and bacteria such as microscopic examination and 
culture. (8-11) 
Broeren et al reported the high percentage of false-negative results in screened negative 
urine samples with the sysmex UF-1000i urine flow cytometer. Broeren et al did not warrant 
the UF-1000i as a screening analyzer. (8)Indeed van der Zwet et al did not recommend urine 
flow cytometer for use in complicated patient populations, such as neutropenic patients and 
patients in whom yeast infection is suspected (9) Manoni et al studied 214 untreated urine 
samples using the Sysmex UF-1000i and compared with results obtained from quantitative 
manual microscopy using the Fuchs-Rosenthal counting chamber. They concluded 
automated urine particle analysis is sufficiently precise and improves the workflow in a 
routine laboratory (10) Williams et al determined that accuracy of microscopy for white cells 
is no better than that of dipstick. Up to 10% of children with a urinary tract infection had 
negative rapid tests. Rapid test cannot replace urine culture (11) 
2.1 Diagnostic imaging studies 
Acute pyelonephritis and reflux diagnosed by several imaging methods; ultrasonography, 
IVP, VCUG , CT , Doppler , DMSC scintigraphy and MRU. Danger of exposure to radiation 
is important in patients.Renal ultrasonography and renal scanning at the time of the acute 
illness are of limited value, because they do not provide information that modifies 
management (12-18) 
3. Renal ultrasonography  
Ultrasonography is a noninvasive test which routinely performed after the diagnosis of a 
first UTI.US has replaced IVP for evaluating the size and shape of the kidneys but is not 
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sensitive enough to detect the presence of hydronephrosis, hydroureter, acute 
pyelonephritis, or renal scarring (11) VUR which affects approximately 30 to 40 percent of 
young children cannot be consistently detected by US has been an important consideration 
in ultrasonography.  
3.1 IVP (IV pyelography) 
Excretory urography, the traditional method of imaging the kidneys replaced by non 
invasive and safe methods in last decades. However, US, CT, MR all provide better images 
of the renal parenchyma. 
3.2 VCUG 
VCUG is used to identify children with vesicoureteral reflux currently performed any time 
after three to four days of therapy. 
Vesicoureteral reflux was graded according to the classification system of the international 
reflux international study committee. Prophylactic therapy recommended in children with 
at least grade ii VUR.  
Otokesh et al compared voiding urosonography  or cystosonography with radio nucleotide 
cystography for evaluation of VUR (12). Sensitivity and specifity of voiding urosonography 
was 87% and 88%, respectively, with a 94% positive predictive value and a 77% negative 
predictive value. It concluded that voiding urosonography is a highly accurate, safe and 
inexpensive tool for the screening, diagnosis and follow-up of VUR.  
3.3 Renal DMSA scans 
Acute pyelonephritis was defined by the presence of focal or diffuse areas of decreased 
uptake of labeled DMSA without evidence of cortical loss or by the presence of diffusely 
decreased uptake in an enlarged kidney (15).  
DMSA scans obtained at presentation and six months later identify children with acute 
pyelonephritis and renal scarring. The degree of scarring was assessed quantitatively by 
outlining the scarred area (15).  
The accuracy of renal artery resistive index (RI) in doppler ultrasonography with DMSA 
scan and VCUG for diagnosis of APN and reflux in pediatrics patients were assessed and 
compared. There is a significant relationship between increased RI and the severity of renal 
involvement.  
3.4 MRU 
In recent years, Dynamic gadolinium –MRU as a new alternative imaging method with free 
of radiation hazards presented by some authors. (16-18).  
Dynamic gadolinium DTPA-enhanced MR urography has been shown to give high-quality 
views of the morphology of the obstructed urinary tract and an accurate evaluation of 
urinary excretion (17). 
Zarabi et al observed good agreement between MRU and DMSA scan in results of 
IVP&VCUG. No agreement presented between MRU and DMSA scan with ultra 
sonographic studies. So, dynamic MRU might be a valuable method in diagnosis of urinary 
tract anomalies like as hydronephrosis, obstractive uropathy, congenital malformation, 
pyelonephritis, renal scar (18). 
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The contrast medium used in MRU is also less toxic and with fewer adverse effects than the 
radiographic contrast medium used in conventional IVP .Although the economic aspect is 
still problematic and needing for sedation, it is obvious that MR urography will continue to 
increase its role in clinical uro radiology. MR imaging offers a potential to reduce the need 
for invasive retrograde pyelography. (16-18) 
4. UTI Treatment 
UTI is caused by E. coli in over 80% of cases and treatment is a course of antibiotics. The uro 
pathogens other than E coli in the gastrointestinal tract were selected while children were 
receiving antibiotic prophylaxis (1-4).  
Due to acute illness caused by UTI and the risk of pyelonephritis-induced permanent kidney 
damage, many children are given long-term antibiotics for reducing the recurrence (5-7) The 
risk of delayed versus early treatment of acute pyelonephritis in children is not well defined 
and renal scarring would be investigated (8) The prophylactic antibiotic was not effective in 
reducing bacterial colonization of the prepuce. Some uro pathogens might have come from 
the external genitalia (19-20). 
4.1 Modes of antibiotic administration 
The optimal route for antibiotic therapy oral (PO) or intravenous (IV) versus intramuscular 
administration is not clear. Consensus guidelines from the 1990s still recommend IV 
antibiotics. (1-5) 
The American Academy of Pediatrics recommended early antibiotic treatment, given 
parenterally if necessary in febrile infants and young children suspected of having a UTI  
(1-4). 
Treatment failure for generally healthy young infants hospitalized with utis is uncommon 
and is not associated with the duration of intravenous antibiotic treatment. Severity of 
illness and the presence of known abnormalities of the genitourinary tract, but not young 
age, were associated with increased risk for treatment failure. (3, 4) 
As intravenous antibiotic therapy is associated with side effects, toxicity, high cost, and long 
hospitalization period in treatment of UTIs (4,5) Switch therapy (intravenous-to-oral 
antibiotic) has been considered . Clinicians should consider PO antibiotics for these children 
who are nontoxic and have close parental and follow-up care. Treating more infants with 
short-course intravenous antibiotic therapy would decrease the length of hospitalization for 
children and families without affecting the readmission rate. (5, 6) 
Recently, the national institute for health and clinical excellence published treatment 
guidelines advocating PO antibiotics in uncomplicated patients as young as three months of 
age controlled trials for choice of antibiotics in children with acute pyelonephritis. There are 
no data on PO antibiotics for UTIs in infants younger than one month of age due to higher 
risks of bacteremia, meningitis and nonspecific findings, these children would benefit from 
conservative IV antibiotics. (1-5)  
Some authors reported no different results for renal scarring and serious adverse events 
between IV and PO antibiotic groups. PO antibiotic therapy for children with UTIs has the 
advantages of ease and cost over IV therapy. (24-30) 
The lack of association between the length of intravenous antibiotic therapy and subsequent 
treatment failure reported in recent years. In a prospective, randomized trial the incidence of 
renal scars was similar in patients who received 3 days compared 8 days of intravenous 
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ceftriaxone. Increased renal height at initial ultrasound examination and grade 3 VUR were 
significant risk factors for renal scars. (28-30)  
Hodson et al identified po antibiotics appear to be as effective as initial IV antibiotics for 
UTIs in children older than one month of age with no known structural urological 
abnormality. (24) 
Perri et al reported the oral antibiotics equivalent to intravenous antibiotics for the initial 
management of pyelonephritis in children .Two nuclear radiologists interpreted the renal 
scans independently and resolved any discrepancies by consensus. (27)  
VUR rather than antibiotic choices might affect renal scarring. There was no risk difference 
in renal scarring between treatment groups, despite the presence of VUR. However, these 
children have a higher risk of renal scarring than children without VUR. (28-30)   
The standard antibiotic therapy was sequential IV cefotaxime or ceftriaxone for three days, 
followed by cefixime , amoxi -clavulanate or ceftibutin for either seven days or 11 days 
versus the same total duration with po antibiotics alone. (25-30) 
Noorbakhsh et al (2004) compared the efficacy and safety of ceftriaxone with switch to 
cefixime, 8 mg/kg once a day with aminoglycoside therapy in urinary tract infections. 
Response rate in cases with switch therapy was higher than children treated with 
intravenous aminoglycoside (88% vs. 80%; p value = 0.82). Most of those patients had a 
favorable clinical/microbiologic response assessment at the 7 days post therapy. (25) 
Mertz et al (26) reported the  acceptable rate of response both clinically and 
microbiologically in children, who received ceftriaxone with switch to cefixime.   
Cefixime, ceftibuten and amoxicillin / clavulanic acid recommended for oral antibiotics, or 
with short courses (2 to 4 days) of IV therapy followed by oral therapy. If IV therapy is 
chosen, single daily dosing with aminoglycosides is safe and effective. (25-30) 
Cefixime is a third-generation oral cephalosporin that is highly active against a broad range 
of gram-negative and some gram-positive aerobic bacteria, and has a low rate of side effects.  
On the basis of the literature data, cefixime could be indicated in the treatment of UTIs in 
children either as monotherapy or as switch therapy. (25, 26) 
Resistance to common PO antibiotics may be greater in UTI cases with prophylactic drugs 
(21-30)  Several risk factors explained for the emergence of resistant organisms, including 
underlying genitourinary  tract abnormalities, in-hospital treatment of UTI (19,20) previous 
antibiotic exposure, history of previous UTI. (21-23 ) 
5. UTI management 
The prevention of renal scars by early and appropriate antibiotics is essential. (1, 2)APN can 
induce irreversible renal scars, with a risk for hypertension or chronic renal failure at long-
term follow-up. (3, 4)  
In all children with a previous febrile urinary tract infection, the routine performance of 
urinalysis, urine culture, or both during subsequent febrile illnesses is needed. (4-10) 
However, different approaches to management considered on age of children: children 
under 1 year; young children (1–4, 5, or 7 years, depending on the information source); and 
older children (up to 12–16 years). [12-18]  
Approximately 60 to 65 percent of imaging studies will be abnormal in children younger 
than 2 years who have a first febrile UTI (12-14).Currently DMSA scans, is the best way to 
detect renal scars, the percentage of residual renal scars after first APN episode has been 
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shown to vary between 25% and 60%(15) Parenchymal defects on DMSA reported in 36% of 
all involved kidneys and at least one scarred kidney in 59% of children with VUR. VUR was 
a weak predictor of renal damage in children admitted to hospital. Local or systemic 
immune problems are factors in the development of UTI. (14) 
VUR runs in families. The incidence of reflux ranged from 26% in asymptomatic siblings to 
86% in symptomatic (UTI) siblings in compare with a rate of less than 1% in the general 
population. No clear link has yet been established between specific genes and an adverse 
outcome. (14, 15) 
5.1 Prophylactic treatment 
A widespread practice has been to initiate long-term prophylactic antimicrobial therapy in 
children found to have VUR (1, 2) The currently recommended antibiotics, including co - 
trimoxazole, nitrofurantoin, and nalidixic acid or amoxicillin- clavulanate (5-7). Greater 
antimicrobial resistance observed in patients receiving antibiotic prophylaxis (21-23) Except 
in 1 study, with co- trimoxazole prophylaxis , decreased antimicrobial susceptibilities were 
as prominent as those in children receiving cephalexin or cefaclor prophylaxis. (19-23)  
Although concerns have existed that VUR may be a risk factor for recurrent UTIs, recent 
findings had not showed an increased risk of treatment failure (eg recurrence of fever or 
positive urine culture) in children with VUR. (21-30) 
Attitudes toward the use of prophylactic antibiotics had changed during last decade. 
Previous empirical approach, which has recently been questioned, was based on an 
international study conducted in the 1980s that compared medical management (i.e 
prophylactic antimicrobial therapy) with surgical management of VUR and did not include 
an observation group as a control. A meta - analyses in prevention and treatment of UTI had 
done. The useful ness of empirical prophylactic antimicrobial therapy had not confirmed  by 
Masson et al study. (22)  
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